The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Résumé La toxicité myocardique est un effet indésirable grave lié à un grand nombre de traitements anticancéreux. Elle peut altérer la qualité de vie, mais aussi la survie des patients atteints ou ayant survécu à un cancer. Classiquement, elle est définie par une diminution significative de la fraction d’éjection ventriculaire gauche (FeVG) mesurée par échographie, scintigraphie ou IRM cardiaque....
Opinion statement Both conventional and novel antineoplastic drugs may cause damage to the heart, ultimately affecting patients’ survival and quality of life. In fact, the most frequent and typical clinical manifestation of cardiotoxicity, asymptomatic or symptomatic left ventricular dysfunction, may be induced not only by conventional cancer therapy, like anthracyclines, but also by new antitumoral...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.